Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation f

来源 :22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会) | 被引量 : 0次 | 上传用户：binga2009

【摘要】

：

【作者】

：

Chen Zhang Yu-Qing Song Jun Zhu Xiao-Pei Wang Zhi-Tao Ying Ling-Yan Ping Wen Zheng Yan Xie Ning-Jing Lin Wei-Ping Liu Li-Juan Deng

【机构】

：

Peking University Cancer Hospital & Institute,Department of Lymphoma,Key Laboratory of Carcinogenesi

【出处】

：

22nd Asia Pacific Cancer Conference(第22届亚太抗癌大会)

【发表日期】

：

2013年7期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

Objective: To investigate the efficacy of purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation (APBSCT) in patients with aggressive B-cell non-Hodgkin lymphoma.Methods: A total of 26 patients diagnosed with aggressive B-cell non-Hodgkin lymphoma in our hospital from January2005 to December 2012 were retrospectively analyzed.All patients received infusion of rituximab at a dose of 375 mg/m2for four times, including one before peripheral blood stem cell mobilization, one before stem cell collection, one before highdose therapy, and one on the day of leukocyte engraftment.

其他文献

Rituximab, gemcitabine, cisplatin, and dexamethasone for patients with refractory or relapsed aggres

This study was conducted to evaluate the efficacy and safety of rituximab, gemcitabine, cisplatin, and dexamethasone(R-GDP) for the treatment of relapsed or refractory aggressive B-Cell non-Hodgkins l

会议

High expression of cell division cycle 7 protein correlates with poor prognosis of patients with dif

Diffuse large B-cell lymphoma (DLBCL) is the most common form of lymphoma.According to the clinical risk factors and biological heterogeneity, clinical outcome of DLBCL extremely varies, with 5-year s

会议

Risk factors of the early recurrence of HBV-related hepatocellular carcinoma meeting the Milan Crite

Objective: To investigate the risk factors of the early recurrence(recurrence-free time ≤1 year) of HBV-related HCC that meets the Milan Criteria after curative resection.Methods: A retrospective anal

会议

D-dimer and fibrinogen in serum have a close correlation with the prognosis of hepatocellular carcin

Objective: To study the prognostic significance of the serum levels of D-dimer and fibrinogen in hepatocellular carcinoma(HCC) patients treated with chemoembolization.Methods: The prognostic factors i

会议

The prognostic values of BAFF and APRIL serum levels in patients with follicular lymphoma

Objective: B-cell activation factor (BAFF) and a proliferationinducing ligand (APRIL) play crucial roles in the survival and proliferation of B cells.Elevated BAFF and APRIL serum levels have been rep

会议

Transfection of chimeric anti-CD138 gene enhances natural killer cell line NK-92MI activation and ki

Objective: Multiple myeloma (MM) cells have been shown to be insensitive to NK-92-mediated killing.The adoptive immunotherapy with NK cells reprogramming with a chimeric antigen receptor (CAR) proved

会议

Correlation between the clinical features and immunological subtypes of diffuse large B-cell lymphom

Objective: To analyze the related factors between the clinical features and immunological subtypes of diffuse large B-cell lymphoma in Uyghu and Han patients.Methods: A total of 167 cases of DLBCL fro

会议

Expressions of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteri

Objective: To determine the expression profiles of BAFF and BAFF-R in FL tumor tissue and FL cell line and to evaluate the correlation of BAFF and BAFF-R expressions with clinicopathologic characteris

会议

Research on Janus kinase inhibitor AG4gO combined with anticancer and targeted drugs on diffuse larg

Objective: To investigate whether AG490 combined with regular chemotherapy and targeted drugs may provide a new therapeutic approach for the treatment of DLBCL.Methods: DLBCL cells cultured in RPMI-16

会议

Antitumor effects of Endostar on non-Hodgkins lymphoma by regulating endothelial progenitor cells th

Objective: the anti-angiogenic activities of Endostar on NHL cell lines and murine xenograft model of NHL in vitro and in vivo, and explored the underlying antiangiogenic mechanism of Endostar.Methods

会议

Purging with rituximab in vivo combined with autologous peripheral blood stem cell transplantation f

其他学术论文